MX2018011166A - Composiciones, dispositivos y metodos de prueba de sensibilidad de fibromialgia. - Google Patents
Composiciones, dispositivos y metodos de prueba de sensibilidad de fibromialgia.Info
- Publication number
- MX2018011166A MX2018011166A MX2018011166A MX2018011166A MX2018011166A MX 2018011166 A MX2018011166 A MX 2018011166A MX 2018011166 A MX2018011166 A MX 2018011166A MX 2018011166 A MX2018011166 A MX 2018011166A MX 2018011166 A MX2018011166 A MX 2018011166A
- Authority
- MX
- Mexico
- Prior art keywords
- value
- methods
- compositions
- fibromyalgia
- devices
- Prior art date
Links
- 230000035945 sensitivity Effects 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 208000001640 Fibromyalgia Diseases 0.000 title 1
- 238000002360 preparation method Methods 0.000 abstract 2
- 238000003149 assay kit Methods 0.000 abstract 1
- 238000010998 test method Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
- G01N33/6857—Antibody fragments
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/02—Nutritional disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/10—Musculoskeletal or connective tissue disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/24—Immunology or allergic disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2842—Pain, e.g. neuropathic pain, psychogenic pain
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662308348P | 2016-03-15 | 2016-03-15 | |
| PCT/US2017/022349 WO2017160869A1 (en) | 2016-03-15 | 2017-03-14 | Compositions, devices, and methods of fibromyalgia sensitivity testing |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2018011166A true MX2018011166A (es) | 2019-03-28 |
Family
ID=59850607
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2018011166A MX2018011166A (es) | 2016-03-15 | 2017-03-14 | Composiciones, dispositivos y metodos de prueba de sensibilidad de fibromialgia. |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20190145972A1 (enExample) |
| EP (1) | EP3430403A4 (enExample) |
| JP (2) | JP2019510226A (enExample) |
| CN (1) | CN109073648A (enExample) |
| AU (1) | AU2017235312A1 (enExample) |
| CA (1) | CA3056368A1 (enExample) |
| MX (1) | MX2018011166A (enExample) |
| WO (1) | WO2017160869A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102375614B1 (ko) | 2014-11-14 | 2022-03-16 | 바이오메리카인코포레이티드 | Ibs 민감도 테스트 구성, 장치 및 방법 |
| JP2019510226A (ja) * | 2016-03-15 | 2019-04-11 | バイオメリカ・インコーポレイテッドＢｉｏｍｅｒｉｃａ， Ｉｎｃ． | 線維筋痛症感受性試験の組成物、デバイスおよび方法 |
| EP3497447B1 (en) | 2016-07-08 | 2024-09-04 | Biomerica, Inc. | Compositions, devices, and methods of depression sensitivity testing |
| WO2022133467A1 (en) | 2020-12-17 | 2022-06-23 | Cummins Inc. | Combustion cylinder end face components including thermal barrier coatings |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6689569B2 (en) * | 2001-08-14 | 2004-02-10 | Immunosciences Lab., Inc. | Saliva test for detection of food allergy, candidiasis, microflora imbalance, intestinal barrier dysfunction and humoral immunodeficiencies |
| GB0310522D0 (en) * | 2003-05-08 | 2003-06-11 | Yorktest Lab Ltd | Assay panel |
| US7601509B2 (en) * | 2004-07-15 | 2009-10-13 | Power Laura W | Biotype diets system: predicting food allergies by blood type |
| CN101166760A (zh) * | 2005-02-15 | 2008-04-23 | 阿波罗生命科学有限公司 | 分子及其嵌合分子 |
| DE202006009206U1 (de) * | 2006-03-14 | 2007-03-29 | Bieger, Wilfried P., Priv.-Doz. Dr.med.habil. | Testbestecks zur Bestimmung von neuroendokrinen gesundheitlichen Störungen |
| WO2009035529A1 (en) * | 2007-09-10 | 2009-03-19 | Immunohealth International, Llc | Method of analysis, detection and correction of food intolerance in humans |
| EP3181705A1 (en) * | 2008-11-12 | 2017-06-21 | Caris Life Sciences Switzerland Holdings GmbH | Methods and systems of using exosomes for determining phenotypes |
| WO2010118761A1 (en) * | 2009-04-17 | 2010-10-21 | Eolas Science Limited | Compositions rich in omega-3 fatty acids with a low content in phytanic acid |
| GB201002601D0 (en) * | 2010-02-16 | 2010-03-31 | Microtest Matrices Ltd | Allergen microarray |
| CA2813064C (en) * | 2010-09-29 | 2021-06-01 | Uti Limited Partnership | Methods for treating autoimmune disease using biocompatible bioabsorbable nanospheres |
| US9694045B2 (en) * | 2010-12-03 | 2017-07-04 | Sinil Pharmaceutical Co., Ltd. | Pharmaceutical composition for preventing or treating inflammatory diseases comprising trachelospermi caulis extract and paeonia suffruticosa andrews extract, and method for preparing the same |
| GB2490652A (en) * | 2011-04-18 | 2012-11-14 | Microtest Matrices Ltd | Methods of quantifying antibodies, especially IgE antibodies in a sample |
| US20130149336A1 (en) * | 2011-10-27 | 2013-06-13 | Brian L. Hjelle | Methods for Screening Viral Like Particles and Identifying Neutralizing Epitopes and Related Vaccines, Constructs, and Libraries |
| US20150004189A1 (en) * | 2012-02-07 | 2015-01-01 | La Jolla Institute For Allergy And Immunology | Epitopes from allergen proteins and methods and uses for immune response modulation |
| EP2657707A1 (en) * | 2012-04-26 | 2013-10-30 | B.R.A.H.M.S GmbH | Biomakers for the diagnosis, prognosis, assessment and therapy stratification syncope |
| TWI677507B (zh) * | 2012-06-22 | 2019-11-21 | 達特茅斯學院基金會 | 新穎之ｖｉｓｔａ－ｉｇ構築體及ｖｉｓｔａ－ｉｇ用於治療自體免疫、過敏及發炎病症之用途 |
| CN202814976U (zh) * | 2012-07-31 | 2013-03-20 | 白仲虎 | 一种用于食品不耐受性检测的检测组件 |
| EP2893061B1 (en) * | 2012-09-05 | 2019-05-22 | Arizona Board of Regents, a Body Corporate of the State of Arizona acting for and on behalf of Arizona State University | Methods for discovering therapeutic targets |
| WO2014066894A1 (en) * | 2012-10-26 | 2014-05-01 | Case Western Reserve University | Biomarkers for nod2 and/or rip2 activity related application |
| US10426403B2 (en) * | 2013-05-08 | 2019-10-01 | The Board Of Trustees Of The Leland Stanford Junior University | Methods of testing for allergen sensitivity |
| KR102375614B1 (ko) * | 2014-11-14 | 2022-03-16 | 바이오메리카인코포레이티드 | Ibs 민감도 테스트 구성, 장치 및 방법 |
| JP2019510226A (ja) * | 2016-03-15 | 2019-04-11 | バイオメリカ・インコーポレイテッドＢｉｏｍｅｒｉｃａ， Ｉｎｃ． | 線維筋痛症感受性試験の組成物、デバイスおよび方法 |
-
2017
- 2017-03-14 JP JP2018548869A patent/JP2019510226A/ja active Pending
- 2017-03-14 MX MX2018011166A patent/MX2018011166A/es unknown
- 2017-03-14 CA CA3056368A patent/CA3056368A1/en active Pending
- 2017-03-14 WO PCT/US2017/022349 patent/WO2017160869A1/en not_active Ceased
- 2017-03-14 AU AU2017235312A patent/AU2017235312A1/en not_active Abandoned
- 2017-03-14 CN CN201780026236.4A patent/CN109073648A/zh active Pending
- 2017-03-14 EP EP17767358.9A patent/EP3430403A4/en not_active Ceased
-
2018
- 2018-09-14 US US16/131,281 patent/US20190145972A1/en not_active Abandoned
-
2021
- 2021-12-10 JP JP2021201193A patent/JP2022022426A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2019510226A (ja) | 2019-04-11 |
| US20190145972A1 (en) | 2019-05-16 |
| CA3056368A1 (en) | 2017-09-21 |
| JP2022022426A (ja) | 2022-02-03 |
| WO2017160869A1 (en) | 2017-09-21 |
| EP3430403A4 (en) | 2019-08-14 |
| EP3430403A1 (en) | 2019-01-23 |
| AU2017235312A1 (en) | 2018-10-04 |
| CN109073648A (zh) | 2018-12-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2021009297A (es) | Composiciones, dispositivos, y metodos de pruebas de sensibilidad del ibs. | |
| Srivastava | Why have measures of earnings quality changed over time? | |
| BR112017007965A2 (pt) | método implantado por computador para inferir a atividade de uma via de sinalização celular de tgf-b em um indivíduo; aparelho para inferir a atividade de uma via de sinalização celular de tgf-b em um indivíduo; meio de armazenamento não transitório; programa de computador; kits para medir níveis de expressão de três ou mais genes-alvo da via de sinalização celular de tgf-b em uma amostra de um indivíduo; inferir a atividade de uma via de sinalização celular de tgf-b em um indivíduo; inferir a atividade de uma via de sinalização celular de tgf-b em um indivíduo; e uso do kit | |
| MX2023005293A (es) | Composiciones, dispositivos y metodos de prueba de sensibilidad a la depresion. | |
| SG11201900126YA (en) | Object selection method and apparatus | |
| CA2961701C (en) | Method and system for determining the local quality of surface data extracted from volume data | |
| MX365944B (es) | Aparato y metodo para colorear pelo personalizado. | |
| EP3839510A3 (en) | Blood-based biomarkers of tumor sensitivity to pd-1 antagonists | |
| BR112018002848A2 (pt) | método, aparelho, mídia de armazenamento não transitório, programa de computador, kit para medir níveis de expressão de seis ou mais genes-alvo da via de sinalização celular | |
| MX2018011166A (es) | Composiciones, dispositivos y metodos de prueba de sensibilidad de fibromialgia. | |
| WO2015160415A3 (en) | Systems and methods for visual sentiment analysis | |
| MX2023006660A (es) | Composiciones, dispositivos, y metodos de pruebas de sensibilidad a la osteoartritis. | |
| MX2018007567A (es) | Composiciones, dispositivos y métodos de prueba de sensibilidad a los alimentos de personas con psoriasis. | |
| MX2024000466A (es) | Composiciones, dispositivos y metodos de pruebas de sensibilidad a la enfermedad de crohn. | |
| MX2021000899A (es) | Composiciones y metodos para determinar el pronostico de cancer de endometrio. | |
| MY187907A (en) | Methods and snp detection kits for predicting palm oil yield of a test oil palm plant | |
| MX2018010856A (es) | Composiciones, dispositivos y metodos de pruebas de sensibilidad de dispepsia funcional. | |
| MX2018013120A (es) | Composiciones, dispositivos y metodos de prueba de sensibilidad a la colitis ulcerosa. | |
| MX2018015334A (es) | Composiciones, dispositivos y métodos de prueba de sensibilidad a los alimentos a la enfermedad de reflujo gastroesofageal. | |
| MX391844B (es) | Metodo y aparato para estimar la cantidad de microorganismos en una unidad taxonomica en una muestra. | |
| WO2015166353A3 (en) | Early detection of preeclampsia | |
| MX2023005604A (es) | Composiciones, dispositivos, y metodos de prueba de sensibilidad para el trastorno de deficit de atencion/trastorno de hiperactividad con deficit de atencion (add/adhd). | |
| GB2552271A (en) | A method for diagnosing lung cancer | |
| MX2018007566A (es) | Composiciones, dispositivos y métodos de prueba de sensibilidad a los alimentos de personas con dolor de cabeza por migraña. | |
| MX2019000143A (es) | Composiciones, dispositivos y métodos de prueba de sensibilidad a la depresión. |